Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
SHOC2 encodes a protein that consists almost entirely of leucine-rich repeats, a domain implicated in protein-protein interactions. Additionally we are shipping Soc-2 Suppressor of Clear Homolog (C. Elegans) Proteins (4) and many more products for this protein.
Showing 10 out of 56 products:
Human Polyclonal SHOC2 Primary Antibody for ELISA, WB - ABIN4245891
Lozada, Karlstedt, Panula, Aarnisalo: Unilateral labyrinthectomy induced changes on GDNF receptor complex proteins in the rat medial vestibular nuclei. in Journal of vestibular research : equilibrium & orientation 2007
Show all 2 references for 4245891
Human Polyclonal SHOC2 Primary Antibody for EIA, IHC (fro) - ABIN1109005
Matsunaga-Udagawa, Fujita, Yoshiki, Terai, Kamioka, Kiyokawa, Yugi, Aoki, Matsuda: The scaffold protein Shoc2/SUR-8 accelerates the interaction of Ras and Raf. in The Journal of biological chemistry 2010
Human Polyclonal SHOC2 Primary Antibody for ICC, IF - ABIN4356990
Yi, Chen, Wu, Yang, Xu, Zhuang, Han, Xu: Endothelial SUR-8 acts in an ERK-independent pathway during atrioventricular cushion development. in Developmental dynamics : an official publication of the American Association of Anatomists 2010
Results provide evidence that SHOC2 trapping at different subcellular sites has a diverse impact on ERK (show EPHB2 Antibodies) signaling strength and dynamics, suggesting a dual counteracting modulatory role of SHOC2 in the control of ERK (show EPHB2 Antibodies) signaling exerted at different intracellular compartments.
Data suggest that SUR-8 may act in an ERK (show EPHB2 Antibodies)-independent pathway to regulate AVC development.
Erbin (show ERBB2IP Antibodies) has a regulatory role in the Ras-Raf (show RAF1 Antibodies)-MEK (show MDK Antibodies) pathway and may inhibit ERK (show EPHB2 Antibodies) activation by disrupting the Sur-8-Ras/Raf (show RAF1 Antibodies) interaction
results demonstrate that PSMC5 (show PSMC5 Antibodies) is a new and important player involved in regulating ERK1/2 (show MAPK1/3 Antibodies) signal transmission through the remodeling of Shoc2 scaffold complex in a spatially-defined manner.
Noonan-like syndrome has been related to the invariant c.4A > G missense change in SHOC2.
Two unrelated Taiwanese patients have been described with Noonan-like syndrome with loose anagen hair who also have moyamoya disease and in whom heterozygous germline mutation in SHOC2 was found.
ectopic overexpression of human Shoc2 in PC12 cells significantly promotes neurite extension in the presence of Epidermal Growth Factor (show EGF Antibodies), a stimulus that induces proliferation rather than differentiation in these cells.
Extreme phenotypic variability associated with the invariant SHOC2 c.4A>G (p.Ser2Gly) missense mutation in Noonan-like syndrome with loose anagen hair.
A newborn heterozygous for the invariant c.4A>G missense change in SHOC2.
Data show that both Shoc2 and HUWE1 (show HUWE1 Antibodies) are necessary to control the levels and ubiquitination of the Shoc2 signaling partner, RAF-1 (show RAF1 Antibodies).
Both MRAS (show MRAS Antibodies) and SHOC2 play a key role in polarized migration.
SHOC2 and CRAF (show RAF1 Antibodies) mediate ERK1/2 (show MAPK1/3 Antibodies) reactivation in mutant NRAS (show NRAS Antibodies)-mediated resistance to RAF (show RAF1 Antibodies) inhibitor.
This gene encodes a protein that consists almost entirely of leucine-rich repeats, a domain implicated in protein-protein interactions. The protein may function as a scaffold linking RAS to downstream signal transducers in the RAS/ERK MAP kinase signaling cascade. Mutations in this gene have been associated with Noonan-like syndrome with loose anagen hair.
Ras-binding protein SUR-8
, leucine-rich repeat protein SHOC-2
, protein soc-2 homolog
, protein sur-8 homolog
, suppressor of clear, C. elegans, homolog of
, Protein soc-2 homolog
, Protein sur-8 homolog